Search research articles
Contact Us
Filters
Showing results (181-190 of 347) with videos related to
Page
of 35
Sort By:
Frontiers in Neuroscience
|
September 26, 2022
Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task
Mylène Duivon, Joy Perrier, Carine Segura-Djezzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2012
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
Laurence Albiges, Stéphane Oudard, Sylvie Negrier, et al.
The Oncologist
|
December 31, 2025
Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study
Florence Joly, Claudia Lefeuvre-Plesse, Emilie Charton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer
Catherine Lhommé, Florence Joly, Joan L Walker, et al.
BMC Cancer
|
August 18, 2017
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Marie Lange, Heidi Laviec, Hélène Castel, et al.
European Journal of Haematology
|
November 20, 2022
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study
Alexander Röth, Catherine M Broome, Wilma Barcellini, et al.
BMC Cancer
|
September 5, 2018
Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study
Mylène Duivon, Joy Perrier, Florence Joly, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 3, 2012
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial
Stéphanie Lheureux, Sophie Krieger, Béatrice Weber, et al.
The Oncologist
|
July 31, 2016
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
Marie Lange, Natacha Heutte, Olivier Rigal, et al.
Journal of Pain and Symptom Management
|
September 8, 2015
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Page
of 35
Search research articles
Search
Showing results (181-190 of 347) with videos related to
Sort By:
Page
of 35
Frontiers in Neuroscience
|
September 26, 2022
Sleep-dependent memory consolidation in breast cancer: Use of a virtual reality prospective memory task
Mylène Duivon, Joy Perrier, Carine Segura-Djezzar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 11, 2012
Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
Laurence Albiges, Stéphane Oudard, Sylvie Negrier, et al.
The Oncologist
|
December 31, 2025
Home-based supervised exercise on metastatic cancer patients receiving oral targeted therapy: the AFSOS-Unicancer QUALIOR randomized phase 2 study
Florence Joly, Claudia Lefeuvre-Plesse, Emilie Charton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 30, 2008
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer
Catherine Lhommé, Florence Joly, Joan L Walker, et al.
BMC Cancer
|
August 18, 2017
Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol
Marie Lange, Heidi Laviec, Hélène Castel, et al.
European Journal of Haematology
|
November 20, 2022
Sutimlimab provides clinically meaningful improvements in patient-reported outcomes in patients with cold agglutinin disease: Results from the randomised, placebo-controlled, Phase 3 CADENZA study
Alexander Röth, Catherine M Broome, Wilma Barcellini, et al.
BMC Cancer
|
September 5, 2018
Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study
Mylène Duivon, Joy Perrier, Florence Joly, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 3, 2012
Expected benefits of topotecan combined with lapatinib in recurrent ovarian cancer according to biological profile: a phase 2 trial
Stéphanie Lheureux, Sophie Krieger, Béatrice Weber, et al.
The Oncologist
|
July 31, 2016
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment
Marie Lange, Natacha Heutte, Olivier Rigal, et al.
Journal of Pain and Symptom Management
|
September 8, 2015
Impact of Cancer and Its Treatments on Cognitive Function: Advances in Research From the Paris International Cognition and Cancer Task Force Symposium and Update Since 2012
Florence Joly, Bénédicte Giffard, Olivier Rigal, et al.
Page
of 35